EUCTR2013-004956-39-DE进行中（未招募）1 期
Study to evaluate the impact of donor-specific HLA-antibodies on graft function and survival after renal transplantation - Long term follow up of the SMART study population
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients who have participated in the former SMART Trial will be included, if the give written informed consent to participate in the present study.
- •The main inclusion criteria into the SMART study were:
- •- Male end female patients between 18 and 65 years of age who were scheduled to receive renal transplantation
- •- first and second renal transplantation
- •- PRA (panel reactive antibody titers) <= 30%
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 100
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Missing written informed consent
- •Patient do not come to the follow up visit within 3 months
研究者
相似试验
招募中
2 期
HLA-mismatched unrelated HCT using PTCyJPRN-jRCTs051220057Kuno Masatomo29
招募中
不适用
A study of the relationship between the HLA-DR beta 1 genotype and therapeutic response of abatacept (ABT) in patients with rheumatoid arthritis (RA)Rheumatoid arthritisJPRN-UMIN000020046Matsuyama Red Cross Hospital130
已完成
不适用
Interest of the Donor-specific Antibodies After Liver TransplantationLiver TransplantNCT03238443University Hospital, Lille120
招募中
2 期
Clinical trial for HLA-haploidentical transplantation using alpha-beta T cell and B cell depletioJPRN-jRCTs032230287Iguchi Akihiro3
已完成
1 期
A phase I/II trial of HLA haploidentical peripheral blood stem cell transplantation following reduced-intensity conditioningChronic myeloid leukemia, Acute myeloid leukemia, Acute lymphoid leukemia, Myelodysplastic syndrome, Malignant lymphomaJPRN-C000000253Health and Labour Sciences Research Grants, Research on Human Genome, Tissue Engineering, Ministry of Health, Labour and Welfare25